Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation Miami Valves 2024

Impella Assisted Bifurcation PCI of Severely Calcified Unprotected LM using RotaShock Technique

Presenter: Ruthvik Srinivasamurthy

February 03, 2024

Presentation CHIP Seattle 2018

What Do You Mean the Impella Won’t Come Out?

Presenter: Duane Pinto

August 11, 2018

Presentation

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

April 12, 2018

Presentation SIF 2017

A Great Utilization of Impella

Presenter: Creighton W. Don

March 08, 2017

Presentation SIF 2017

Why Impella (Not Balloon Pump) Should Be Used Most Often in Cardiogenic Shock

Presenter: Douglas Drachman

March 08, 2017

Presentation TCT 2013

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary...

Presenter: William O'Neill

October 31, 2013

Presentation TCT 2012

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Presenter: George Dangas

October 23, 2012

Presentation TCT 2012

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Presenter: Brijeshwar Maini, William O?Neill, Simon Dixon, Igor Palacios, Theodore Schreiber, David A. Gregory, D. J. Scotti

January 03, 2012

Advertisement

Impella Assisted Bifurcation PCI of Severely Calcified Unprotected LM using RotaShock Technique

What Do You Mean the Impella Won’t Come Out?

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

A Great Utilization of Impella

Why Impella (Not Balloon Pump) Should Be Used Most Often in Cardiogenic Shock

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary...

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content